# Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients

> **NCT04596488** · NA · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 25 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** Efavirenz 400mg

## Key facts

- **NCT ID:** NCT04596488
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04596488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04596488, "Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04596488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*